BioCentury
ARTICLE | Clinical News

Adenovirus delivery: Received approval of a Phase I/II

September 26, 1994 7:00 AM UTC

GenVec, Rockville, Md. Product: Adenovirus delivery of the gene defective in cystic fibrosis Indication: Cystic fibrosis Status: Received RAC approval of a Phase I/II protocol to test safety and effic...